$5.83 -0.21 (-3.48%) TG Therapeutics Inc - NASDAQ

Jul. 22, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 5.83
Trade Time: Jul 22 04:00 PM Eastern Daylight Time
Change: -0.21 (-3.48%)
Prev Close: 6.04
Open: 6.04
Bid: 5.82
Ask: 5.83
  1. No results found.
  1. Jim Cramer Dishes On Microsoft, Gilead, TG Therapeutics & NY Community Bancorp

    Benzinga | Jan. 24, 2016 | 19:56PM EST
  2. TG Therapeutics, Inc. Announces Oral Presentation of Novel Pre-Clinical Combinations With TGR-1202 by Investigators at Columbia University

    Benzinga | Dec. 7, 2015 | 11:30AM EST
  3. TG Therapeutics Announces Data Presentations from Ongoing Clinical Studies in Patients With NHL, CLL at #ASH2015

    Benzinga | Dec. 6, 2015 | 18:57PM EST
  4. Mid-Morning Market Update: Markets Mostly Flat; Rite Aid Earnings Miss Views

    Benzinga | Sep. 17, 2015 | 10:35AM EST
  5. TG Therapeutics, Inc. Launches Phase 1/2 "Triple-Therapy" Study With TGR-1202 + TG-1101 + the PD-1 Checkpoint Inhibitor Pembrolizumab in Patients With Advanced Chronic Lymphocytic Leukemia (CLL) at the University of Pennsylvania's Abramson Cancer Center

    Benzinga | Sep. 9, 2015 | 08:32AM EST
  6. TG Therapeutics to Present Clinical Data on TG-1101 and TGR-1202 at the 20th Congress of the European Hematology Association and the 13th International Congress on Malignant Lymphoma

    Benzinga | Jun. 11, 2015 | 16:31PM EST
  7. Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG ...

    GuruFocus | Jun. 1, 2015 | 17:15PM EST
  8. TG Therapeutics Announces the Triple Combination of TG-1101, TGR-1202 and Ibrutinib is Safe and Highly Active in Patients With Advanced B-Cell Malignancies

    Benzinga | Jun. 1, 2015 | 11:00AM EST
  9. TG Therapeutics, Inc. Presents Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research Annual Meeting

    Benzinga | Apr. 20, 2015 | 07:31AM EST
  10. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  11. The Top 5 Biotech Gainers Of 2014

    Benzinga | Dec. 29, 2014 | 14:15PM EST
  12. Wainwright Sees TG Therapeutics As Take-Out Target

    Benzinga | Oct. 27, 2014 | 13:20PM EST
  13. UPDATE: H.C. Wainwright Initiates Coverage On TG Therapeutics On Significant Long-Term Upside

    Benzinga | Oct. 27, 2014 | 08:19AM EST
  14. TG Therapeutics Announces Exercise of License Option For Its Novel, Next Generation PI3K-Delta Inhibitor, TGR-1202

    Benzinga | Sep. 23, 2014 | 07:31AM EST
  15. US Stock Futures Down Ahead Of Industrial Production Report

    Benzinga | Sep. 15, 2014 | 07:13AM EST
Trading Center